Gertjan Rasschaert

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.

Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 07, 2026

From tumor regression grading to interpretable endpoints in neoadjuvant oncology.

From tumor regression grading to interpretable endpoints in neoadjuvant oncology.

Journal: NPJ precision oncology
Published: March 16, 2026

Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patients.

Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patients.

Journal: European journal of nuclear medicine and molecular imaging
Published: March 16, 2026

Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative review.

Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative review.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: March 02, 2026

Young onset rectal cancer (YORC): a descriptive tertiary center analysis.

Young onset rectal cancer (YORC): a descriptive tertiary center analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: December 24, 2025

Myeloid-derived PD-L1 characterizes spatially organized immune architecture in colorectal cancer.

Myeloid-derived PD-L1 characterizes spatially organized immune architecture in colorectal cancer.

Journal: Frontiers in immunology
Published: December 08, 2025

Long-term recurrence patterns in rectal cancer after neoadjuvant therapy: 25-years of real-world data.

Long-term recurrence patterns in rectal cancer after neoadjuvant therapy: 25-years of real-world data.

Journal: European journal of cancer (Oxford, England : 1990)
Published: October 23, 2025

The dawn of immunotherapy in mismatch repair proficient colorectal cancer.

The dawn of immunotherapy in mismatch repair proficient colorectal cancer.

Journal: Lancet (London, England)
Published: October 09, 2025

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

Journal: JAMA oncology
Published: July 10, 2025

Regular arrangement of collecting venules as a predictor of Helicobacter pylori absence using white-light endoscopy: a multicenter prospective study outside Asia.

Regular arrangement of collecting venules as a predictor of Helicobacter pylori absence using white-light endoscopy: a multicenter prospective study outside Asia.

Journal: Therapeutic advances in gastrointestinal endoscopy
Published: March 31, 2025

Immunosensitivity cuts across mismatch repair status in colorectal cancer.

Immunosensitivity cuts across mismatch repair status in colorectal cancer.

Journal: Cancer cell
Published: January 15, 2025

Salvage Surgery for Unifocal Progressive Metastatic Mismatch Repair-Deficient GI Cancer Responding to Immune Checkpoint Inhibition.

Salvage Surgery for Unifocal Progressive Metastatic Mismatch Repair-Deficient GI Cancer Responding to Immune Checkpoint Inhibition.

Journal: JCO precision oncology
Published: October 11, 2024
Showing 1-12 of 20

Last Updated: 09/26/2026